USP17L17: A Drug Target / Disease Biomarker (G100287327)
USP17L17: A Drug Target / Disease Biomarker
USP17L17 is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell growth and differentiation, and has been implicated in a number of diseases, including cancer.
One of the key functions of USP17L17 is its role in cell proliferation. This protein plays a vital role in the regulation of cell growth, by controlling the activity of the cell's growth factors. USP17L17 helps to ensure that cells are only allowed to grow and divide at the rate that is necessary for their proper functioning.
Another important function of USP17L17 is its role in cell death. This protein helps to regulate the process of cell death, known as apoptosis. USP17L17 helps to ensure that that cells are only allowed to die when they have fulfilled their useful function, and helps to prevent the unnecessary cell death that can occur in diseases such as cancer.
In addition to its role in cell proliferation and cell death, USP17L17 is also involved in the regulation of inflammation. This protein helps to control the activity of immune cells, and is implicated in the development of inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.
Despite its many important functions, USP17L17 is not yet a well-established drug target or biomarker. This is because while it is known to play a vital role in the regulation of various biological processes, it is not yet clear how it can be used to treat human diseases.
However, USP17L17 is an attractive target for research because of its potential to be used in a variety of therapeutic approaches. For example, it could be used to treat diseases that are characterized by uncontrolled cell growth, such as cancer. By inhibiting the activity of USP17L17, it may be possible to slow down or even reverse the growth of cancer cells.
Another potential approach to using USP17L17 involves using it as a biomarker. This is because the protein is expressed in a variety of tissues and is often used as a marker for diseases such as cancer. By detecting the level of USP17L17 in tissues, it may be possible to diagnose or monitor the progression of certain diseases.
Overall, USP17L17 is a protein that has the potential to be a drug target or biomarker. While more research is needed to fully understand its functions and potential therapeutic uses, its study is an important step towards a better understanding of how this protein contributes to the biology of the body.
Protein Name: Ubiquitin Specific Peptidase 17 Like Family Member 17
Functions: Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes that may include cell proliferation, progression through the cell cycle, apoptosis, cell migration, and the cellular response to viral infection
The "USP17L17 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about USP17L17 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
USP17L18 | USP17L2 | USP17L20 | USP17L21 | USP17L24 | USP17L25 | USP17L26 | USP17L27 | USP17L29 | USP17L3 | USP17L5 | USP17L6P | USP17L7 | USP17L8 | USP17L9P | USP18 | USP19 | USP2 | USP2-AS1 | USP20 | USP21 | USP22 | USP24 | USP25 | USP26 | USP27X | USP27X-DT | USP28 | USP29 | USP3 | USP3-AS1 | USP30 | USP30-AS1 | USP31 | USP32 | USP32P1 | USP32P2 | USP32P3 | USP33 | USP34 | USP35 | USP36 | USP37 | USP38 | USP39 | USP4 | USP40 | USP41 | USP42 | USP43 | USP44 | USP45 | USP46 | USP46-DT | USP47 | USP48 | USP49 | USP5 | USP50 | USP51 | USP53 | USP54 | USP6 | USP6NL | USP6NL intronic transcript 1 (non-protein coding), transcript variant 1 | USP7 | USP8 | USP8P1 | USP9X | USP9Y | USPL1 | UST | UTF1 | UTP11 | UTP14A | UTP14C | UTP15 | UTP18 | UTP20 | UTP23 | UTP25 | UTP3 | UTP4 | UTP6 | UTRN | UTS2 | UTS2B | UTS2R | UTY | UVRAG | UVSSA | UXS1 | UXT | UXT-AS1 | VAC14 | Vacuolar H+ ATPase | VAMP1 | VAMP2 | VAMP3 | VAMP4
